소 타일레리아병의 약독화 백신
    33.
    发明授权
    소 타일레리아병의 약독화 백신 有权
    소타일레리아병의약독화백신

    公开(公告)号:KR100430936B1

    公开(公告)日:2004-05-14

    申请号:KR1020010083879

    申请日:2001-12-24

    Abstract: PURPOSE: An attenuated vaccine prepared by isolating a Theileria sergenti Sungwhan stock from Haemaphysalis longicornis and then attenuating it is provided. The vaccine has recognizable specific protection property and thus can be effectively used in the prevention of bovine theileriosis. CONSTITUTION: An attenuated vaccine is prepared by the steps of: recovering Haemaphysalis longicornis imagoes from bovines infected with theileriosis; infecting a rabbit with the Haemaphysalis longicornis imagoes for 6 to 7 days; and aseptically collecting salivary gland from the collected Haemaphysalis longicornis imagoes. The vaccine is formed into an injectable formulation.

    Abstract translation: 目的:提供一种减毒疫苗,它是通过从长角血蜱Haemaphysalis longicornis中分离泰勒虫(Theileria sergenti Sungwhan),然后减毒来制备的。 该疫苗具有可识别的特异性保护特性,因此可有效用于预防牛泰勒虫病。 组成:减毒疫苗是通过以下步骤制备的:从感染泰勒氏菌病的牛中回收长角血蜱(Haemaphysalis longicornis)成虫; 用长角血蜱成虫感染兔子6至7天; 并从收集的Haemaphysalis longicornis成虫中无菌收集唾液腺。 疫苗形成可注射制剂。

    T 세포의 PRRSV 증식 억제능 평가 방법
    34.
    发明授权
    T 세포의 PRRSV 증식 억제능 평가 방법 有权
    T细胞PRRSV增殖抑制能力的评价方法

    公开(公告)号:KR101777252B1

    公开(公告)日:2017-09-12

    申请号:KR1020160086210

    申请日:2016-07-07

    Abstract: 본발명은 T 세포의병원체감염세포증식억제능평가방법및 세포억제능에관여하는병원체특이적 T 세포의정보제공방법에관한것이다. 본발명의 T 세포의병원체감염세포증식억제능평가방법은직접적으로돼지를이용하지않고도실험실내 in vitro 상에서평가가능하고, 또한, T 세포가추출된세포의개체와동일개체(autologous) 혹은동일유전자형을가진다른개체(heterologous)에대한 PRRSV 증식억제를확인할수 있는효과가있어, 백신및 면역증강제의효능평가분야에유용하게이용할수 있다.

    Abstract translation: 本发明涉及一种评估T细胞抑制病原体感染细胞增殖能力的方法和一种提供涉及细胞抑制的病原体特异性T细胞信息的方法。 和本发明的细胞的Ť病原体感染的细胞增殖的抑制能力评价方法对体外实验室评估,而无需使用直接猪,也时,T细胞被提取的信元的对象,并且在同一个体(自体)或相同的基因型 本发明可以用于评价疫苗和免疫刺激剂的功效,因为它具有证实对其他异源个体的PRRSV增殖抑制的作用。

    재조합 베큘로바이러스, 재조합 베큘로바이러스를 포함하는 바이러스 유사입자 및 돼지 신종인플루엔자 바이러스 감염 억제용 백신
    36.
    发明公开
    재조합 베큘로바이러스, 재조합 베큘로바이러스를 포함하는 바이러스 유사입자 및 돼지 신종인플루엔자 바이러스 감염 억제용 백신 无效
    重组细菌病毒,含有重组禽流感病毒的病毒样颗粒和疫苗限制性SWINE流感病毒感染

    公开(公告)号:KR1020130063850A

    公开(公告)日:2013-06-17

    申请号:KR1020110130447

    申请日:2011-12-07

    Abstract: PURPOSE: A recombinant baculovirus is provided to protect a swinery from novel swine-origin influenza A(H1N1) and to prevent new or variant virus expressed in a pig. CONSTITUTION: A recombinant baculovirus is prepared by inserting a gene which expresses HA(hemagglutinin), a gene which expresses NA(neuraminidase), and a gene which expresses M1(matrix 1) protein. The HA expressing gene is a gene(GeneBank FJ966082) which expresses HA of influenza virus A/California/04/2009(CA09). The NA expressing gene is a gene(GeneBank FJ966084) which expresses NA of influenzavirus A/California/04/2009(CA09). The M1 protein expressing gene is a gene(GeneBank FJ969513) which expresses M1 protein of influenza virus A/California/04/2009(CA09). A VLP(Virus-Like Particle) for suppressing swine influenza viral infection contains the recombinant baculovirus. A vaccine for suppressing swine influenza viral infection contains the VLP. [Reference numerals] (AA) Tn7L,Tn7R sequence homologous recombination for Baculovirus

    Abstract translation: 目的:提供重组杆状病毒以保护猪只免受猪源甲型H1N1流感病毒侵袭,并防止在猪中表达的新病毒或变异病毒。 构成:通过插入表达HA(血凝素)的基因,表达NA(神经氨酸酶)的基因和表达M1(基质1)蛋白质的基因来制备重组杆状病毒。 HA表达基因是表达流感病毒A / California / 04/2009(CA09)的HA的基因(GeneBank FJ966082)。 NA表达基因是表达流感病毒A / California / 04/2009(CA09)的NA的基因(GeneBank FJ966084)。 M1蛋白表达基因是表达流感病毒A / California / 04/2009(CA09)的M1蛋白的基因(GeneBank FJ969513)。 用于抑制猪流感病毒感染的VLP(病毒样颗粒)含有重组杆状病毒。 用于抑制猪流感病毒感染的疫苗包含VLP。 (AA)Tn7L,Tn7R序列同源重组杆状病毒

    지질 이중층 상에 말단 에폭시기를 갖는 고체 입자 및 그를 제조하는 방법
    37.
    发明公开
    지질 이중층 상에 말단 에폭시기를 갖는 고체 입자 및 그를 제조하는 방법 有权
    具有末端环氧基团的固体颗粒在脂质双层上的制备及其制备方法

    公开(公告)号:KR1020120055385A

    公开(公告)日:2012-05-31

    申请号:KR1020100117104

    申请日:2010-11-23

    Abstract: PURPOSE: A solid particle having end epoxy radical on lipid bilayer and a manufacturing method thereof are provided to uniformly fix molecules having amino radicals under mild condition. CONSTITUTION: A solid particle having end epoxy radical includes lipid bilayer coated with polyelectrolyte material on a surface. The lipid bilayer comprises a first lipid molecule and a second lipid molecule. The first lipid molecule is diacetylene having the first lipid molecule having epoxy radical in the end. The second lipid molecule is a different lipid molecule from the first lipid molecule. A solid particle before being coated with the polyelectrolyte material is negative charged material. A cationic polyelectrolyte material and electronegative polyelectrolyte material are coated by turns.

    Abstract translation: 目的:提供在脂质双层上具有末端环氧基的固体颗粒及其制备方法,以均匀地固定温和条件下具有氨基的分子。 构成:具有末端环氧基的固体颗粒包括在表面上用聚电解质材料涂覆的脂质双层。 脂质双层包含第一脂质分子和第二脂质分子。 第一脂质分子是具有最终具有环氧基的第一脂质分子的乙炔。 第二脂质分子是与第一脂质分子不同的脂质分子。 在用聚电解质材料涂覆之前的固体颗粒是负带电材料。 阳离子聚电解质材料和电负极聚电解质材料被轮转涂覆。

    돼지콜레라 바이러스 Erns 단백질 및 이에 특이적으로반응하는 단클론항체를 이용한 돼지콜레라 항체 감별진단방법
    40.
    发明公开
    돼지콜레라 바이러스 Erns 단백질 및 이에 특이적으로반응하는 단클론항체를 이용한 돼지콜레라 항체 감별진단방법 有权
    SWINE FEVER VIRUS ERNS蛋白质和筛选和检测与其相似的SWINE FEVER病毒抗体的方法

    公开(公告)号:KR1020070116382A

    公开(公告)日:2007-12-10

    申请号:KR1020060050357

    申请日:2006-06-05

    Abstract: A method for screening and detecting a swine fever virus antibody is provided to easily screen and diagnose infected swine fever virus antibody by using a monoclonal antibody specifically reacting with a recombinant swine fever virus Erns protein and secure constant sensitivity regardless of all genotypes of the swine fever virus when using all three kinds of recombinant protein. A recombinant swine fever virus Erns is prepared by expressing a gene encoding three Erns proteins among swine fever viruses having various genotypes using baculovirus. A method for preparing a monoclonal antibody specifically reacting to the Erns comprises the steps of: (a) constructing a swine fever virus LOM strain-derived Erns recombinant gene using a baculovirus expression system; and (b) producing the monoclonal antibody using the recombinant Erns protein. A method for screening and detecting a swine fever virus antibody comprises the steps of: (a) mixing three kinds of Erns recombinant proteins at proper concentration to prepare an antigen cocktail; (b) after diluting the antigen cocktail into a coating buffer solution, pouring it in a plate to be absorbed into the plate; (c) washing the recombinant antigen not-absorbed into the plate to remove it; (d) adding a sample to be tested to the plat to allow the reaction; (e) washing the sample to be tested not specifically bound to the recombinant Erns antigen protein absorbed into the plate to remove it; (f) adding a monoclonal antibody not being bound to the enzyme but being specifically reacted to the Erns protein to allow the reaction; (g) washing the monoclonal antibody not being bound to the recombinant Erns antigen protein absorbed into the plate to remove it; and (h) adding a substrate reacting with the enzyme to determine the swine fever virus infection.

    Abstract translation: 提供了一种筛选和检测猪瘟病毒抗体的方法,通过使用与重组猪瘟病毒Erns蛋白特异性反应的单克隆抗体轻松筛选和诊断感染的猪瘟病毒抗体,无论猪瘟的所有基因型如何 使用全部三种重组蛋白的病毒。 通过使用杆状病毒在具有各种基因型的猪瘟病毒中表达编码三种Erns蛋白质的基因来制备重组猪瘟病毒Erns。 制备与Erns特异性反应的单克隆抗体的方法包括以下步骤:(a)使用杆状病毒表达系统构建猪瘟病毒LOM菌株衍生的Erns重组基因; 和(b)使用重组Erns蛋白产生单克隆抗体。 筛选和检测猪瘟病毒抗体的方法包括以下步骤:(a)以适当浓度混合三种Erns重组蛋白以制备抗原混合物; (b)将抗原混合物稀释到涂布缓冲溶液中后,将其倒入板中吸收到板中; (c)将未吸收的重组抗原洗涤到板中以除去它; (d)将待测试样品加入平板以允许反应; (e)洗涤待测试的样品,未特异性地结合到吸收到板中的重组Erns抗原蛋白质以除去它; (f)加入未结合酶的单克隆抗体,但与Erns蛋白特异性反应以进行反应; (g)洗涤未结合到吸附到板中的重组Erns抗原蛋白的单克隆抗体以除去它; 和(h)加入与酶反应的底物以确定猪瘟病毒感染。

Patent Agency Ranking